Baralgetas tablets 500 mg #10

Baralgetas tablets 500 mg #10
Manufactured by: Serbia
Product Code: 9895

Qty:  BUY
You can buy Baralgetas tablets 500 mg #10 here.

10 tablets 500 mg


Migraine, toothache, headache, neuritis

Mild to moderate pain syndrome spasms of smooth muscles of internal organs - renal and hepatic colic, spastic nature of the pain during bowel algomenorrhea. Can be used for short-term symptomatic treatment for pains in the joints, neuralgia, sciatica, myalgia.

As an additional tool can be used to reduce pain in consequence of surgical and diagnostic procedures.

If needed, the product can be used to reduce elevated body temperature in cold and infectious and inflammatory diseases.

Pharmacological Effects:

The product includes: non-narcotic analgesic, metamizol sodium (analgin) myotropic pitofenone antispasmodic and anticholinergic agent m-fenpiveriniya bromide.

Metamizol is a pyrazolone derivative. Possesses analgesic, antipyretic and anti-inflammatory action.

Pitofenone, like papaverine, has a direct myotropic effect on smooth muscles of internal organs and causes it to relax.

Fenpiveriny by M-anticholinergic action exerts additional relaxing effect on smooth muscles.

The combination of the three components of a product leads to pain relief, relaxation of smooth muscle, decrease body temperature.


If ingestion is part of the product metamizol sodium is rapidly and completely absorbed. T1 / 2 is achieved by 1.4 hours, is metabolized in the liver to form 4-N-metilaminofenazona, 4-aminofenazona, 4-N-atsetilaminofenazona and 4-N-formilaminofenazona. T1 / 2 of the main metabolite 4-N-metilaminofenazona is 1,8-4,6 hours, crosses the placenta and breast milk. Excreted through the kidneys.

Baralgetas (Baralgetas) Dosage and administration:

Adults and children over 15 years, administered orally (preferably in a later meal) usually 1 - 2 tablets 2 - 3 times each day. The daily dose is not required to exceed 6 tablets. Duration receiving no more than 5 days.

Increasing the daily dose of the product or the duration of treatment is possible only with the advice and under medical supervision.

Dosages for the kids.

Babies, the product is used only on prescription.

The dosage for children 6-8 years old - at half the pill, 9-12 years - three quarters of the tablets, 13-15 years old - one tablet 2-3 times daily. Other modes of dosages are possible only in the later advice of a doctor.

Parenteral (IV, V / m). Adults and adolescents over 15 years with acute severe colic administered IV slowly (1 ml over 1 min) to 2 ml, if necessary, re-enter after 6-8 hours / m - 2.5 ml of 2.3 times each day. The daily dose must not exceed 10 ml. Duration of treatment - no more than 5 days. Calculation of the dose for toddlers at I / and / m the introduction: 3-11 months (5-8 kg) - Only in / m - 0.1-0.2 ml, 1-2 years (9-15 kg) - I / - 0.1-0.2 ml / m - 0.2-0.3 ml, 3-4 years (16-23 kg) - I / - 0.2-0.3, / m - 0.3-0.4 ml, 5-7 years (24-30 kg) - I / - 0.3-0.4 ml / m - 0.4-0.5 ml; 8-12 years (31-45 kg) - I / - 0.5-0.6 ml / m - 0.6-0.7 ml; 12-15 years - in / and / m - 0.8-1 ml. Before the introduction of injectable solution should be warm in his hand.

Baralgetas (Baralgetas) contraindications:

Hyperresponsiveness (including pyrazolone derivative), inhibition of bone marrow hematopoiesis, severe hepatic and / or renal failure, deficiency of glucose-6-phosphate dehydrogenase, tachyarrhythmias, severe angina, decompensated CHF, angle-closure glaucoma, prostatic hyperplasia (with clinical manifestations), E. obstruction, megacolon, collapse, pregnancy (especially in I trimester and in posledstviidnie 6 weeks), during lactation. For iv administration - infancy (up to 3 months) or body weight less than 5 kg. Tablet - childhood (up to 5 years). C care. Renal / hepatic failure, bronchial asthma, "Aspirin" triad, a tendency to hypotension, hyperresponsiveness to other nonsteroidal anti-inflammatory products.

Drug Interactions:

Solution for injection pharmaceutically incompatible with other drugs. At a joint appointment with the H1-histamine blockers, butyrophenone, phenothiazine, tricyclic antidepressants, amantadine and quinidine may increase the M-anticholinergic action. Strengthens the effects of ethanol, the simultaneous application of chlorpromazine and other phenothiazine derivatives may lead to severe hyperthermia. Tricyclic antidepressants, oral contraceptives, and allopurinol may increase the toxicity of the product. Phenylbutazone, barbiturates and other gepatoinduktory while appointing reduce the effectiveness of metamizol sodium. Sedative and anxiolytic drugs (tranquilizers) enhance analgesic effect of metamizol sodium. Radiopaque drugs, colloidal blood substitutes and penicillin should not be used during treatment with products containing metamizol sodium. When concomitant administration of cyclosporine decreased concentration posledstviidnego in the blood. Metamizol sodium, displacing from its association with protein oral hypoglycemic drugs, indirect anticoagulants, corticosteroids and indomethacin, may increase the severity of their actions. Tiamazol and cytotoxic agents increase the risk of leukopenia. Amplify the effect of codeine, H2-blockers of histamine receptors and propranolol (slow inactivation of metamizol sodium).

Baralgetas (Baralgetas) side effects:

Allergic reactions: urticaria (including the conjunctiva and mucous membranes of nose and throat), angioedema, in rare cases - malignant exudative erythema (Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell's syndrome), bronhospasticheskih syndrome, anaphylactic shock. With the urinary system: Renal, oliguria, anuria, proteinuria, interstitial nephritis, urine staining in red. Cardio-vascular system: blood pressure reduction. On the part of hematopoiesis: thrombocytopenia, leukopenia, agranulocytosis (may show the following symptoms: unmotivated rise in temperature, chills, sore throat, difficulty swallowing, stomatitis, and development of the phenomena of vaginitis, or proctitis). Anticholinergic effects: dry mouth, decreased sweating, paresis of accommodation, tachycardia, difficulty urinating. Local reaction: when i / m administration may infiltrate into place vvedeniya.Peredozirovka. Symptoms: vomiting, decreased blood pressure, drowsiness, confusion, nausea, pain in the epigastric region, liver function and kidney failure, seizures. Treatment: gastric lavage, the appointment of activated charcoal, symptomatic therapy.


Tablets - 10 tablets in a blister pack. Carton contains 10 blisters and instructions for medical use.

Solution for intravenous and intramuscular administration (ampoule dark glass) 5 ml.

Baralgetas (Baralgetas) composition:

Valium tablets from white to light yellow in color with beveled and scored on one side. Allowed marbling.

Each tablet contains:

Active ingredients: metamizol sodium - 500 mg, pitofenone hydrochloride - 5,0 mg fenpiveriniya bromide - 0.1 mg;

Excipients: lactose, starch, sodium hydrogen carbonate, talc, magnesium stearate.

Each vial contains:

metamizol sodium 500 mg, 2 mg pitofenone, fenpiveriniya bromide 20 micrograms, auxiliary substances (water for injection, hydrochloric acid 1 mol / L) - 1 ml.

Storage Conditions:

List B. At temperatures below 25 ° C in a dry, dark place out of reach of children.

Conditions of supply - by prescription.


During treatment the product is not recommended for ethanol. With a long (more than a week) treatment is necessary to monitor patterns of peripheral blood and liver functional state. If you suspect the presence of agranulocytosis, or thrombocytopenia should stop using the product. Must not be used for relief of acute abdominal pain (to determine the cause). Use in nursing mothers requires a cessation of breastfeeding. Intolerance occurs very infrequently, but the threat of anaphylactic shock in consequence of intravenous injection of the product is relatively higher than in the Effect of the substance inside. In cases of atopic asthma and hay fever have an increased risk of allergic reactions. Parenteral administration should be used only in cases where ingestion is not possible (or disturbed absorption from the gastrointestinal tract). Special care with the introduction of more than 2 mL (risk of a sharp reduction of blood pressure). Intravenous injection should hold slowly in the "lying" and under the control of blood pressure, heart rate and BH. When treating kids under 5 years old and the sick, receiving cytotoxic drugs, receiving metamizol sodium should be done only under medical supervision. For IM injection is necessary to use a long needle. Possible staining of urine into the red due to excretion of metabolites (the clinical significance has not). During the treatment should be cautious drivers of vehicles and persons engaged in potentially hazardous activities that require the speed of physical and mental reactions.

Write a review

Note: this form is for product reviews only. To contact us please use contact page.

Your Name:

Your Review: Note: HTML is not translated!

Rating: Bad            Good

Enter the code in the box below: